Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-05-18

FDA Approved: ACZONE — Supplemental Application (Almirall, LLC)

View source ↗

Summary

The FDA approved a supplemental application for ACZONE (dapsone) submitted by Almirall, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ACZONE (DAPSONE)

Snippet

SUPPL AP for ACZONE (DAPSONE)